CPT code 86328 is used for the detection of antibodies against SARS-CoV-2 (COVID-19) using an immunoassay. This code may be used for a variety of clinical scenarios, including:
- Diagnosis of COVID-19: A patient who presents with symptoms of COVID-19 may undergo testing using an immunoassay to detect antibodies against SARS-CoV-2.
- Assessment of Immune Status: Individuals who have been vaccinated against COVID-19 may undergo antibody testing to assess their immune response to the vaccine.
- Monitoring of Disease Progression: Patients with COVID-19 may undergo serial testing to monitor the progression of the disease and their immune response.
CPT code 86769 is used for the detection of antigens of SARS-CoV-2 (COVID-19) using an immunoassay. This code may be used for a variety of clinical scenarios, including:
- Diagnosis of COVID-19: A patient who presents with symptoms of COVID-19 may undergo testing using an immunoassay to detect antigens of SARS-CoV-2.
- Screening: Individuals who have been exposed to someone with COVID-19 may undergo antigen testing to determine if they are infected with SARS-CoV-2.
- Monitoring of Disease Progression: Patients with COVID-19 may undergo serial testing to monitor the progression of the disease and the presence of SARS-CoV-2 antigens.
Note that the use of these codes may vary based on the specific guidelines of different payers and the interpretation of the clinician.